Can lowering brain oxidative stress ease anxiety in MS?

Credibility

Interest

Share:2 min read

Key Takeaway

Too much of a brain protein called TAF15 can raise oxidative stress and cause anxiety-like problems in mice, and an antioxidant helped reverse these effects.

What They Found

Researchers found higher levels of the protein TAF15 in brain cells of people with some neurodegenerative diseases. In cells and in mice, making neurons produce too much TAF15 caused oxidative stress, which is damage from harmful molecules similar to rusting inside the brain. This stress led to cell damage and reactive changes in support cells called glia, which can make brain problems worse. Mice with extra TAF15 in a part of the brain involved in emotion showed more anxiety and trouble remembering a cue linked to a scary event. Giving an antioxidant called NACA reduced the cell damage and fixed the behavioral problems in mice, suggesting the damage was driven by oxidative stress.

Who Should Care and Why

People with MS and their caregivers should care because MS also involves damage from inflammation and oxidative stress, so this study points to a common process that can harm brain cells. Think of oxidative stress like too many sparks in an engine that slowly cause parts to wear out; reducing those sparks can protect the engine. Patients who notice increased anxiety, memory problems, or worsening fatigue might find it useful to discuss oxidative stress and antioxidant strategies with their care team. Caregivers and clinicians can use these ideas to consider broader brain-protection approaches, not just disease-specific treatments. While the study focused on a different protein and diseases, the basic idea—that lowering damaging oxidative molecules can help brain function—could be relevant to managing symptoms in MS.

Important Considerations

The study looked at a different set of diseases (FTD and ALS) and used mice and cells, so we can’t assume the same results apply directly to people with MS. The antioxidant used (NACA) worked in mice in this experiment but is not a proven, approved treatment for MS symptoms in people. Always talk with your neurologist before trying supplements or new treatments, because safety and interactions with MS medicines need clinical testing.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research Mental Wellness Specific Symptoms

Article Topics:

ALSCP: Cell biologyCP: NeuroscienceFTDROSTAF15neurodegenerationneurotoxicityoxidative stress

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Cell reports often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News